78 related articles for article (PubMed ID: 20813774)
1. MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
Taylor BV; Pearson JF; Clarke G; Mason DF; Abernethy DA; Willoughby E; Sabel C
Mult Scler; 2010 Dec; 16(12):1422-31. PubMed ID: 20813774
[TBL] [Abstract][Full Text] [Related]
2. The increasing prevalence of multiple sclerosis in New Zealand.
Alla S; Pearson J; Debernard L; Miller D; Mason D
Neuroepidemiology; 2014; 42(3):154-60. PubMed ID: 24556851
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis in New Zealand.
Alla S; Mason DF
J Clin Neurosci; 2014 Aug; 21(8):1288-91. PubMed ID: 24503208
[TBL] [Abstract][Full Text] [Related]
4. Latitudinal prevalence gradient of multiple sclerosis in Latin America.
Risco J; Maldonado H; Luna L; Osada J; Ruiz P; Juarez A; Vizcarra D
Mult Scler; 2011 Sep; 17(9):1055-9. PubMed ID: 21551216
[TBL] [Abstract][Full Text] [Related]
5. Trends in body mass index and waist circumference among New Zealand adolescents, 1997/1998-2005.
Utter J; Scragg R; Denny S; Schaaf D
Obes Rev; 2009 Jul; 10(4):378-82. PubMed ID: 19389055
[TBL] [Abstract][Full Text] [Related]
6. Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
Maghzi AH; Etemadifar M; Shaygannejad V; Saadatnia M; Salehi M; Hassanzadeh A
Mult Scler; 2007 Jun; 13(5):673-5. PubMed ID: 17548450
[TBL] [Abstract][Full Text] [Related]
7. The latitude gradient for multiple sclerosis prevalence is established in the early life course.
Sabel CE; Pearson JF; Mason DF; Willoughby E; Abernethy DA; Taylor BV
Brain; 2021 Aug; 144(7):2038-2046. PubMed ID: 33704407
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of multiple sclerosis in Ecuador].
Abad P; Pérez M; Castro E; Alarcón T; Santibáñez R; Díaz F
Neurologia; 2010 Jun; 25(5):309-13. PubMed ID: 20643041
[TBL] [Abstract][Full Text] [Related]
10. Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Taylor BV; Palmer A; Simpson S; Lucas R; ; Simmons RD; Mason D; Pearson J; Clarke G; Sabel C; Willoughby E; Richardson A; Abernethy D
Mult Scler; 2013 Oct; 19(12):1627-31. PubMed ID: 23530001
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of disseminated sclerosis in Christchurch.
Cuningham JA
N Z Med J; 1972 Dec; 76(487):417-8. PubMed ID: 4510411
[No Abstract] [Full Text] [Related]
12. Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.
Niederwieser G; Buchinger W; Bonelli RM; Berghold A; Reisecker F; Költringer P; Archelos JJ
J Neurol; 2003 Jun; 250(6):672-5. PubMed ID: 12796827
[TBL] [Abstract][Full Text] [Related]
13. Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia.
Gregory AC; Shendell DG; Okosun IS; Gieseker KE
Sci Total Environ; 2008 Jun; 396(1):42-51. PubMed ID: 18433841
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of multiple sclerosis in Colombia].
Sánchez JL; Aguirre C; Arcos-Burgos OM; Jiménez I; Jiménez M; León F; Pareja J; Pradilla G; Uribe B; Uribe CS; Villa A; Volcy M; Palacio LG
Rev Neurol; 2000 Dec 16-31; 31(12):1101-3. PubMed ID: 11205538
[TBL] [Abstract][Full Text] [Related]
15. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Maghzi AH; Ghazavi H; Ahsan M; Etemadifar M; Mousavi S; Khorvash F; Minagar A
Mult Scler; 2010 Mar; 16(3):359-61. PubMed ID: 20086021
[TBL] [Abstract][Full Text] [Related]
16. The changing demographic pattern of multiple sclerosis epidemiology.
Koch-Henriksen N; Sørensen PS
Lancet Neurol; 2010 May; 9(5):520-32. PubMed ID: 20398859
[TBL] [Abstract][Full Text] [Related]
17. Timing of birth and risk of multiple sclerosis in the Scottish population.
Bayes HK; Weir CJ; O'Leary C
Eur Neurol; 2010; 63(1):36-40. PubMed ID: 20029213
[TBL] [Abstract][Full Text] [Related]
18. Co-occurrence and clustering of tobacco use and obesity in New Zealand: cross-sectional analysis.
Tobias M; Yeh LC; Jackson G
Aust N Z J Public Health; 2007 Feb; 31(1):19-22. PubMed ID: 17333603
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of familial multiple sclerosis in Hungary.
Fricska-Nagy Z; Bencsik K; Rajda C; Füvesi J; Honti V; Csépány T; Dobos E; Mátyás K; Rózsa C; Komoly S; Vécsei L
Mult Scler; 2007 Mar; 13(2):260-1. PubMed ID: 17439894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
